相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis
J Heller et al.
LIVER INTERNATIONAL (2005)
Chronic administration of losartan, an angiotensin II receptor antagonist, is not effective in reducing portal pressure in patients with preascitic cirrhosis
D Tripathi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation
A Rimola et al.
TRANSPLANTATION (2004)
Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
S Yokohama et al.
HEPATOLOGY (2004)
Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study
WD Venom et al.
JOURNAL OF HEPATOLOGY (2003)
Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension
V Croquet et al.
JOURNAL OF HEPATOLOGY (2002)
Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C
Y Terui et al.
HEPATOLOGY (2002)
The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis
F Wong et al.
HEPATOLOGY (2002)
One-week losartan administration increases sodium excretion in cirrhotic patients with and without ascites
YY Yang et al.
JOURNAL OF GASTROENTEROLOGY (2002)
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
M Schepke et al.
GASTROENTEROLOGY (2001)
Hepatic stellate cells as a target for the treatment of liver fibrosis
R Bataller et al.
SEMINARS IN LIVER DISEASE (2001)
Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis
J González-Abraldes et al.
GASTROENTEROLOGY (2001)
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
R Bataller et al.
GASTROENTEROLOGY (2000)
Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis
N Girgrah et al.
GUT (2000)